Patent No. EP3054929 (titled "Muco-Adhesive, Controlled Release Formulations Of Levodopa And/Or Esters Of Levodopa And Uses Thereof") was filed by Impax Laboratories on Oct 7, 2014. The application was issued on Aug 5, 2020.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
| Company | Opposition Date | Representative |
|---|---|---|
| LUIGI | May 5, 2021 | TER MEER STEINMEISTER & PARTNER |
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
May 9, 2025
May 9, 2025
May 9, 2025
Mar 26, 2025
Mar 26, 2025
Feb 18, 2025
Feb 18, 2025
Feb 17, 2025
Feb 17, 2025
Feb 17, 2025
Feb 17, 2025
Feb 14, 2025
Feb 14, 2025
Feb 14, 2025
Nov 6, 2024
Nov 6, 2024
Apr 26, 2024
Apr 26, 2024
Apr 26, 2024
Apr 23, 2024
Apr 18, 2024
Aug 4, 2023
Jul 31, 2023
Jul 31, 2023
Jul 31, 2023
Jul 31, 2023
Jul 31, 2023
Jul 31, 2023
Jul 31, 2023
Jul 31, 2023
Jul 31, 2023
Jul 31, 2023
Jul 31, 2023
Jul 31, 2023
Jul 31, 2023
Jul 31, 2023
Jul 31, 2023
Jul 31, 2023
Jul 31, 2023
Jul 31, 2023
Jul 31, 2023
Jul 31, 2023
Jul 31, 2023
Mar 21, 2023
Mar 20, 2023
Mar 15, 2023
Mar 15, 2023
Mar 15, 2023
Mar 15, 2023
Mar 15, 2023
Feb 8, 2023
Feb 8, 2023
Jan 24, 2023
Jan 24, 2023
Jan 24, 2023
Nov 18, 2022
Nov 18, 2022
Nov 18, 2022
Nov 18, 2022
Nov 18, 2022
Nov 18, 2022
Nov 18, 2022
Nov 18, 2022
Nov 18, 2022
Nov 18, 2022
Nov 18, 2022
Nov 18, 2022
Nov 18, 2022
Nov 18, 2022
Nov 18, 2022
Nov 15, 2022
Nov 15, 2022
Sep 29, 2022
Aug 4, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 29, 2022
Jul 21, 2022
Jul 18, 2022
Jul 18, 2022
Jul 18, 2022
Jun 15, 2022
Jun 15, 2022
Jun 10, 2022
Jun 10, 2022
Jun 8, 2022
Jun 7, 2022
Jun 1, 2022
Jun 1, 2022
May 26, 2022
May 26, 2022
May 26, 2022
Dec 30, 2021
Dec 21, 2021
Dec 16, 2021
Dec 16, 2021
Dec 16, 2021
Dec 16, 2021
Dec 16, 2021
Dec 16, 2021
Sep 23, 2021
Sep 17, 2021
Sep 17, 2021
Sep 17, 2021
Sep 17, 2021
Sep 17, 2021
Sep 17, 2021
Sep 17, 2021
Sep 17, 2021
Sep 17, 2021
Jul 6, 2021
Jul 6, 2021
Jun 29, 2021
May 21, 2021
May 21, 2021
May 14, 2021
May 5, 2021
May 5, 2021
May 5, 2021
May 5, 2021
May 5, 2021
May 5, 2021
May 5, 2021
May 5, 2021
May 5, 2021
May 5, 2021
May 5, 2021
Aug 17, 2020
Jul 9, 2020
Jun 24, 2020
Jun 24, 2020
Jun 24, 2020
Jun 24, 2020
Jun 24, 2020
Apr 9, 2020
Apr 4, 2020
Apr 4, 2020
Mar 16, 2020
Mar 16, 2020
Mar 16, 2020
Mar 16, 2020
Mar 16, 2020
Oct 28, 2019
Oct 28, 2019
Mar 26, 2019
Mar 26, 2019
Mar 26, 2019
Mar 26, 2019
Mar 26, 2019
Mar 26, 2019
Mar 26, 2019
Nov 19, 2018
Nov 19, 2018
Oct 11, 2018
Aug 24, 2018
Aug 24, 2018
Nov 14, 2017
Nov 14, 2017
Nov 14, 2017
Sep 25, 2017
Sep 25, 2017
May 10, 2017
Apr 20, 2017
Apr 20, 2017
Apr 20, 2017
Apr 20, 2017
Apr 4, 2017
Nov 11, 2016
Nov 11, 2016
Nov 11, 2016
Sep 5, 2016
Jul 20, 2016
May 13, 2016
May 11, 2016
May 11, 2016
May 11, 2016
May 11, 2016
Apr 28, 2016
Apr 5, 2016
Apr 5, 2016
Feb 19, 2016
May 6, 2015
Apr 16, 2015
Apr 16, 2015